P1.01-16 First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 positive NSCLC: A Network Meta-Analysis of Randomized Trials

Authors :: Mark Doherty
S. Delos Santos
A. Putri Rahmadian
Kelvin K. W. Chan
Source :: Journal of Thoracic Oncology. 13:S465-S466
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Chemotherapy
business.industry
First line
medicine.medical_treatment
Pembrolizumab
PD-L1 Positive
law.invention
Randomized controlled trial
law
Internal medicine
Meta-analysis
Medicine
business

Tools